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Abstract
Individuals with type 1 diabetes have to monitor their blood glucose levels, determine the quantity of insulin required 
to achieve optimal glycaemic control and administer it themselves subcutaneously, multiple times per day. To help 
with this process bolus calculators have been developed that suggest the appropriate dose. However these calculators 
do not automatically adapt to the specific circumstances of an individual and require fine-tuning of parameters, a 
process that often requires the input of an expert.
To overcome the limitations of the traditional methods this paper proposes the use of an artificial intelligence 
technique, case-based reasoning, to personalise the bolus calculation. A novel aspect of our approach is the use of 
temporal sequences to take into account preceding events when recommending the bolus insulin doses rather than 
looking at events in isolation.
The in silico results described in this paper show that given the initial conditions of the patient, the temporal 
retrieval algorithm identifies the most suitable case for reuse. Additionally through insulin-on-board adaptation and 
postprandial revision, the approach is able to learn and improve bolus predictions, reducing the blood glucose risk 
index by up to 27% after three revisions of a bolus solution.
Keywords: case-based reasoning, temporal, diabetes, feature selection, knowledge based systems,
similarity measures
1. Introduction
Type 1 diabetes mellitus (also known as T1DM)
is a medical condition in which insulin-producing
cells in the pancreas are destroyed and the body
can no longer produce the hormone, insulin, which
in turn means that blood glucose is no longer ab-
sorbed by other cells including fat cells and muscle
cells. This leads to high blood glucose levels that
can have serious health consequences. A comple-
mentary hormone, glucagon, is secreted when blood
glucose levels fall too low. Patients with T1DM
typically have to manage blood glucose levels by
introduction of insulin themselves through periodic
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monitoring of blood glucose levels and an insulin-
injection regime, a complex task even for the most
motivated individual [1].
Bolus insulin calculators have been shown to be
eective in assisting the management of the con-
dition [2]. However, these bolus calculators will al-
ways produce the same result from the user's inputs
unless certain settings such as the carbohydrate-
to-insulin ratio (CIR) and insulin sensitivity factor
(ISF) are altered, a process often guided through
clinicians. Our research aims to address this is-
sue by replacing the static formula with the ability
to learn and improve bolus recommendations auto-
matically through case-based reasoning (CBR).
The contributions of this research are a novel
temporal approach to enhance case retrieval by
identifying the most similar sequences of events;
the incorporation of an adaptation rule for active
insulin in a temporal context; and a postprandial
(post-meal) revision algorithm to allow the system
to learn. Additionally, a detailed comparison of
single-attribute evaluation algorithms included in
the Weka data mining tool for the purpose of fea-
ture weighting in the similarity measure is also car-
ried out as part of this research [3].
This paper is organised as follows. Section 2 ex-
plains the fundamentals of CBR, highlighting the
limitation of using cases in isolation in temporal
domains where events in the past has consequences
in the current actions such as T1DM. In Section
3 we describe our method for solving this problem
using temporal CBR. In Section 4 we discus and
analyse Weka's dierent single-attribute feature se-
lection algorithms, adopted for the purpose of fea-
ture weighting in case retrieval. This is followed
by details of the data and statistical measures used
for evaluating the proposed methodology in Section
5. Section 6 outlines the in silico results of this
approach, showing the system's ability to improve
results over time. Limitations and improvements
in the proposed system are discussed in Section 7.
Related work in the T1DM domain and temporal
CBR is discussed in Section 8. Finally, conclusions
reached are discussed in Section 9.
2. Case-based Reasoning
Case-based reasoning attempts to mimic the hu-
man ability to recall similar situations that oc-
curred in the past and adapt them to address new
problems. The foundations of CBR can be found
in the work conducted by Kolodner based on the
idea of dynamic memory modelling proposed by
Schank [4, 5]. Several applications were developed
to demonstrate the capabilities of CBR for solving
real world problems, notable seminal examples in-
clude CHEF, MEDIATOR, and CASEY [6, 7, 8].
The primary knowledge store in CBR is the case-
base, which is a collection of situations, scenarios,
or events. Each case contains values for a set of
features and a corresponding solution. In the case
of T1DM, the features could be carbohydrates in-
gested, physical activity, time of the day, and other
patient data, with the solution being the bolus in-
sulin recommendation. The goal of CBR is to iden-
tify the case that best reects the current situation
and to adapt it to solve a new problem. One widely
adopted CBR model is the R4 model (Figure 1)
proposed by Aamodt and Plaza [9]. The R4 model
consists of four stage cycle: retrieve, reuse, revise,
and retain. First, a new problem is presented to
the system consisting of features and feature-values,
then a similar case is retrieved. The retrieved case
is then reused to solve the new problem; this may
involve some form of adaptation to resolve any dis-
crepancies between the proposed problem and the
retrieved case. A solution is then presented and
revised by the user or system. If the proposed solu-
tion is accepted it is then retained in the case-base
as a new case. This cycle then repeats to enable
the system to continuously improve suggestions as
its knowledge (case-base) grows.
Figure 1: R4 CBR cycle [9]
The majority of research and development using
CBR considers each case as an isolated event. In
the context of T1DM we believe that temporal ef-
fects should be factored into the retrieval step so
that an individual's recent events can be taken into
account. Research into temporal CBR has been
relativity limited, with the majority of methods re-
quiring specialist case representation, e.g. [10, 11].
To overcome this, sequences of continuous temporal
cases that are linked to each other can be merged
into a singular case [12]. This method allows the
temporal sequences to be compared using standard
distance metrics (e.g. Euclidean distance) without
the need for additional rules. Plausible episodes are
generated from a new problem, which are then com-
pared to similar retrieved episodes in order to solve
the new problem. We use this formation of episodes
as the foundation for our temporal approach.
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3. Methodology
This section describes our proposed temporal
CBR system (Figure 2) for insulin bolus advice
[13, 14] based on the R4 model.
Figure 2: Case-based reasoning model for T1DM bolus in-
sulin advice
First we identify the features that are required
to represent a case and determine how the cases for
T1DM bolus are modelled. This is followed by a
description of how each step of the R4 model was
developed and adapted to deal with temporal infor-
mation.
3.1. Case Structure
Unlike other CBR systems where case features
may vary from case to case, in this context the fea-
tures representing a case are well-dened. The ini-
tial step taken by this research was to determine
which parameters are required by bolus calculators.
Through assessment of commercial and freely avail-
able smart phone bolus calculators (Accu-Chek R
Aviva Expert, RapidCalc, Diabetes Personal Cal-
culator, Diabetic Dosage, and InsulinCalc), the pa-
rameters described in Table 1 were identied. The
selection method of the bolus calculator applica-
tions is described by Martin et al. [15].
The parameters shown in Table 1 allow us to de-
scribe the features of a case. It is clear that the
carbohydrate intake, preprandial (pre-meal) blood
glucose level, and target blood glucose level are es-
sential case parameters as they are taking into ac-
count by all the calculators assessed.
The Insulin Sensitivity Factor (ISF) and
Carbohydrate-to-Insulin Ratio (CIR) are the pri-
mary parameters used to tune the bolus calcula-
tor. However, these factors will be omitted from
the cases. This is due to the fact that the ISF and
CIR values are usually dened as personal settings
on the device, and largely remain static for dierent
time periods. As a result, the majority of cases will
retain the same ISF and CIR for a given time pe-
riod, making them redundant to the CBR retrieval
step. Our CBR approach will instead use the date
and time of the event to infer the ISF and CIR,
which also allows preceding cases to be identied
and used in our temporal case retrieval process.
Insulin-on-board (IOB) is a crucial parameter
which helps to avoid the negative eects of insulin
stacking, caused by administering insulin when
some already remains active in the body. To cater
for IOB, the retrieve step (Section 3.2) uses a
temporal approach that factors in preceding bolus
doses. This is coupled with an adaptation rule in
the reuse step (Section 3.4), which resolves dier-
ences between the IOB in the problem and the re-
trieved case(s) .
Exercise is a parameter that we believe should be
included. However, the UVa/Padova T1DM simu-
lator [16] used in this research did not allow this
to be modelled, so it was excluded in the results
shown in this paper.
Finally, the solution needs to be retained by the
case for reuse in solving new problems. The solution
is this approach is the bolus dose. This will also
serve as a feature in temporal aspect described in
the retrieve step.
In summary, following the assessment of param-
eters used by bolus calculators and the properties
of the reasoning mechanism, the cases will then be
represented by the date and time, carbohydrate in-
take, preprandial blood glucose level, and the solu-
tion of the case will be the recommended bolus.
3.2. Retrieve
The retrieval step is where the temporal aspect
is introduced to the system. As opposed to looking
at the new problem and previous cases in isolation,
we believe the bigger picture should be considered,
most notably preceding events. Events that have
occurred in the recent past may have an eect on
the amount of insulin required now. Whilst the
temporal aspect of CBR has been considered pre-
viously, none of the previous methods appear to be
completely suitable for the task of bolus decision
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Diabetes
Accu-ChekR Personal Diabetic
Parameter Aviva Expert RapidCalc Calculator Dosage InsulinCalc
Carbohydrate intake 3 3 3 3 3
Preprandial blood glucose 3 3 3 3 3
Target blood glucose 3 3 3 3 3
Insulin sensitivity factor 3 3 3 3 3
Carbohydrate-to-insulin ratio 3 3 3 3
Insulin-on-board 3 3 3
Exercise 3 3
Table 1: Parameters used by existing bolus calculators
support. To address this, we propose the use of a
temporal sequence to describe both new problems
and previous cases [12].
Denitions 3.1 through to 3.4 describe the
method more formally. In Def. 3.1 and Def. 3.2
a case and the case-base are dened. Where c rep-
resents the new problem or a retained case, and CB
is the case-base. Denitions 3.3 and 3.4 dene the
temporal problem sequence TP and temporal case
sequence TCn respectively.
Denition 3.1 (Case). A case c is a tuple com-
prised of a number n of features f , and a solution
s.
c = (f1; f2; : : : ; fn; s)
Denition 3.2 (Case-base). A case-base CB is
a sequence of cases ci, where i ranges from 1 to the
size of the case-base jCBj.
CB = hc1; c2; : : : ; cjCBji
Denition 3.3 (Temporal problem sequence).
A temporal problem TP is a sequence comprised of
the individual new problem proposed to the system
c0 and the preceding cases c in the case-base CB.
The size of TP is determined by the dened tempo-
ral sequence length t, where 1  t  jCBj. A TP
with t = 1 will be a sequence containing the new
problem c0, resulting in traditional CBR retrieval
where no previous events are included. For a TP
with t > 1, the sequence must start from t  2 less
than the size of the case-base, because at the very
least the sequence must contain the new problem c0
and the last case in the case-base cjCBj.
TP = hcjCBj (t 2); cjCBj (t 3); :::; cjCBj; c0i
Denition 3.4 (Temporal case sequence). A
temporal case sequence TCn is sequence of t num-
ber of cases c from the case-base CB order by date
and time, with the sequence ending with case n.
The number of cases in the sequence t must be
equal to t in the temporal problem sequence TP
(Def. 3.3).
TCn = hcn (t 1); cn (t 2); : : : ; cni
In the retrieval step, the temporal problem se-
quence TP (Def. 3.3) is compared to sequences in
the case-base TCn (Def. 3.4) of the same temporal
sequence length t. To deal with broken sequences
- those with assumed missing events (gaps) - the
outer fence dened by Tukey is used [17]. Where
such gaps exist, the features are replaced by the
maximum integer distance of 1 on the scale [0, 1].
A weighted distance function is used to compare
the similarity of TP and TCn, this helps to ensure
that the importance of each feature in the overall
similarity is representative of the problem. Weight-
ing each feature in the sequence is a domain depen-
dant task, performed through expert guidance or
automated approaches. One such method for auto-
mated weighting is the use of single-attribute eval-
uators such as the algorithms Information Gain,
Gain Ratio, Symmetrical Uncertainty, Chi-Squared,
One Rule and RELIEF-F [18]. These algorithms
are described in Section 4.
In this research we have adopted the weighted
Euclidean distance function in order to determine
similarity
d(TP; TC) =
vuut IX
i=1
wi (TPi   TCi)2 (1)
where TP and TC is the temporal problem and
temporal case sequences respectively, d is the re-
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sulting distance, I is the total number of features,
and w is the weight of the respective feature.
Prior to computing the distance, all features
should be normalised to avoid unwanted bias of fea-
tures. The closer the distance result is to 0, the
closer the similarity.
At the end of the retrieval step the case(s) that
are more closely related to the current problem are
then reused and further adapted to the current sce-
nario (Section 3.4).
3.3. Worked Retrieval Example
To demonstrate the use of temporal sequences, a
new problem c0 (Table 2) and case-base CB (Table
3) are presented for a temporal sequence of length
2.
The temporal sequence is ordered by the date and
time of the cases such that the most recent case is
the last element of the sequence. The cases are or-
dered sequentially, for example c2 occurs after c1.
TC1 is omitted as there are no previous cases and so
a temporal sequence cannot be formed. Addition-
ally, the new problem solution c0s is not applicable
until it has been solved, for this reason the corre-
sponding feature weighting ws2 is 0.00.
The process begins by rst normalising the fea-
tures f of the case-base CB and new problem c0
in Step 3.1. The process of creating the temporal
sequences and transforming the sequences in to a
new compound case is then illustrated in Step 3.2,
with the example feature weights shown in Table
6. Step 3.3 demonstrates the use of the Euclidean
distance function with this method.
c0c c0bg c0t c0s
carbo- blood time solution
hydrates glucose (minutes) (insulin)
(grams) (mmol/L)
60 3.50 160
Table 2: Example new problem c0
cn cnc cnbg cnt cns
casen carbo- blood time solution
hydrates glucose (mins) (insulin)
(grams) (mmol/L)
c1 50 4.00 120 4.00
c2 30 6.00 240 2.00
c3 60 5.00 180 4.50
Table 3: Example case-base CB
Normalisation of the case features factors in the
feature-values of both the case-base and the new
problem. Step 3.1 demonstrates the normalisation
of the preprandial blood glucose level. The normal-
isation process results in the values shown in Tables
5 and 4.
f = hc0bg; c1  cbg; c2  cbg; c3  cbgi
= h3:50; 4:00; 6:00; 5:00i
fmin = 3:50 fmax = 6:00
n(f1) =
3:50  3:50
6:00  3:50 = 0:00
n(f3) =
6:00  3:50
6:00  3:50 = 1:00
n(f2) =
4:00  3:50
6:00  3:50 = 0:20
n(f4) =
5:00  3:50
6:00  3:50 = 0:60
Step 3.1 (Normalisation).
cn n(cnc) n(cnbg) n(cnt) n(cns)
casen carbo- blood time solution
hydrates glucose (insulin)
c1 0.67 0.20 0.00 0.80
c2 0.00 1.00 1.00 0.00
c3 1.00 0.60 0.50 1.00
Table 4: Example normalised case-base CB
n(c0c) n(c0bg) n(c0t) n(c0s)
carbohydrates blood time solution
glucose
1.00 0.00 0.33 0.00 (n/a)
Table 5: Example normalised new problem c0
In order to improve the retrieval process weights
are dened for the new compound cases. Table 6
shows the weights to be used in this example. The
weights are normalised using the same method as
the features; however, to avoid weights of 0.0, the
minimum and maximum ranges of the feature selec-
tion algorithm are used instead of the minimum and
5
maximum weights returned by the feature selection
algorithm.
wc1 wbg1 wt1 ws1
carbohydrates blood time solution
glucose (insulin)
0.40 0.20 0.10 0.50
wc2 wbg2 wt2 ws2
carbohydrates blood time solution
glucose (insulin)
1.00 0.30 0.20 0.00
Table 6: Example normalised weights for the temporal se-
quence
Step 3.2 (Create the temporal sequence).
TP = hc3; c0i
= h(1:00; 0:60; 0:50; 1:00); (1:00; 0:00; 0:33; 0:00)i
TC2 = hc1; c2i
= h(0:67; 0:20; 0:00; 0:80); (0:00; 1:00; 1:00; 0:00)i
TC3 = hc2; c3i
= h(0:00; 1:00; 1:00; 0:00); (1:00; 0:60; 0:50; 1:00)i
Step 3.3 (Calculate Euclidean distance).
d(TP; TCn) =
vuuuuuuut
jTP jX
i=1
wci(TPic  TCic)2
+ wbgi(TPibg   TCibg)2
+ wti(TPit  TCit)2
+ wsi(TPis  TCis)2
=
vuuuuuuuuuuuuuuuuuut
wc1(TP1c  TC1c)2
+ wbg1(TP1bg   TC1bg)2
+ wt1(TP1t  TC1t)2
+ ws1(TP1s  TC1s)2
+ wc2(TP2c  TC2c)2
+ wbg2(TP2bg   TC2bg)2
+ wt2(TP2t  TC 02t)2
+ ws2(TP2s  TC2s)2
d(TP; TC2) =
vuuuuuuuuuuuuuuuuuut
0:40 (1:00  0:67)2
+ 0:20 (0:60  0:20)2
+ 0:10 (0:50  0:00)2
+ 0:50 (1:00  0:80)2
+ 1:00 (1:00  0:00)2
+ 0:30 (0:00  1:00)2
+ 0:20 (0:33  1:00)2
+ 0:00 (0:00  0:00)2
= 1:23
d(TP; TC3) =
vuuuuuuuuuuuuuuuuuut
0:40 (1:00  0:00)2
+ 0:20 (0:60  1:00)2
+ 0:10 (0:50  1:00)2
+ 0:50 (1:00  0:00)2
+ 1:00 (1:00  1:00)2
+ 0:30 (0:00  0:60)2
+ 0:20 (0:33  0:50)2
+ 0:00 (0:00  1:00)2
= 1:04
In this example, the Euclidean distance function
nds that TC3 is the nearest neighbour when con-
sidering a temporal sequence length of 2 and the
weightings from Table 6. The result of the worked
example is as expected given the weights applied.
However, the distance calculated in both cases is
closer than if just the single case was used; since
the rst cases in the temporal sequences TP and
TC2 (c3 and c2 respectively) share greater similar-
ity than those of the temporal sequences TP and
TC3 (c3 and c2 respectively). However, the method
still considers the importance of the primary case of
the temporal sequences over preceding cases, with
the new problem c0 and last case c3 of the tem-
poral sequence TC3 have identical carbohydrates
ingested values and carbohydrates ingested has the
maximum normalised weight of 1:0. As a result
TC3 is considered to be of greater similarity to TP
than TC2.
3.4. Reuse
For the reuse step we adopted a simple k -NN re-
gression strategy to average the bolus prediction
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of k retrieved cases. Equation 2 denes the reuse
strategy, where k is the number of retrieved cases,
and in denes the bolus solution provided by a re-
trieved case.
suggested bolus dose =
1
k
kX
n=1
in (2)
The result is then adapted to resolve dierences
in the IOB from the new problem to the retrieved
cases to further tune the bolus recommendation.
Whilst the use of temporal sequences somewhat re-
solves this issue, it is important to prevent the neg-
ative eects of insulin stacking. In this research a
linear IOB algorithm (Eq. 3) is adopted [19].
The adapted bolus suggestion is calculated by de-
ducting the average of the sum of the IOBs (iobs,
Eq. 4) for k number of retrieved cases from the
original bolus suggestion i to determine the dier-
ence d0, as described in Eq. 6. For Equations 3 - 6
the variables are dened as follows: the case-base
CB is a sequence of cases c, with each case c a tu-
ple of case time ct in minutes and the bolus dose
ci. t denotes time in minutes, pt is the time of a
new problem in minutes. RC denotes a sequence of
case times in minutes. The active insulin time a is
a constant to reect the duration of a bolus dose in
minutes. The suggested bolus dose i is the original
bolus dose to be adapted.
iob(c; t; a) =
8<:ci

1  t  ct
a

; a > t  ct > 0
0:0; otherwise.
(3)
iobs(CB; t; a) =
jCBjX
n=1
iob(cn; t; a) (4)
d(pt;RC;CB; a) =iobs(CB; pt; a)
 
Pk
n=1 iobs(CB;RCn; a)
k
(5)
d0 =
(
i  d(pt;RC;CB; a); i  d(pt;RC;CB; a)  0
0:0; otherwise.
(6)
3.5. Revise
The revise step is crucial to allow the system
to improve sub-optimal recommendations. The de-
gree of success can be inferred from the dierence
between postprandial (post-meal) blood glucose of
the subject and their target blood glucose level. If
the postprandial reading is equal or close to the
target blood glucose level then the recommenda-
tion can be considered optimal and no revision is
required. However, if the postprandial reading is
higher than the target level, the recommended bo-
lus dose should be increased; otherwise if the post-
prandial reading is lower than the target level, the
bolus dose should be decreased.
To determine this, a method for correcting bolus
doses described by Eq. 8 is used based on the sub-
ject's Total Daily Dose (TDD) to estimate the ISF
(Eq. 7) [20, 21].
To calculate the ISF, University College London
Hospitals suggest the use of the 100 rule for blood
glucose measured in mmol/L, the equivalent for
mg/dL is the 1800 rule [22]. However, Davidson et
al. undertook extensive statistical studies of various
constants and suggest the 1,700 rule, which was ap-
plied to Active Insulin Management (AIM) system
[21, 23]. The 1,700 rule is an established recommen-
dation, and has been used in this research (Eq. 7)
[24]. To convert the ISF from mg/dL to mmol/L,
the ISF is multiplied by the constant 0.0555.
ISF =
1700
TDD
 0:0555 mmol/L (7)
revised bolus =
pbg   tbg
ISF
(8)
To calculate TDD based on guidelines by Univer-
sity College London Hospitals, the sum of 4 days of
bolus and basal insulin doses is divided by four [22].
Equation 9 describes this calculation, where I rep-
resents the sequence of bolus and basal doses over
a period of d days, and Ii is an individual bolus or
basal dose from the sequence of insulin doses I.
TDD =
PjIj
i=1 Ii
d
(9)
In situations where there is not sucient data to
calculate the subject's TDD, then an estimate can
be calculated (Eq. 10) using the subject's body
weight w in pounds [23].
TDD = 0:24 w (10)
One diculty to overcome is when to perform the
postprandial blood glucose reading. If it occurs too
soon after the dose was administered or too late
then the revision is likely to be sub-optimal. To de-
termine this, in silico evaluation for 2, 3 and 4-hour
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osets are conducted, with the results presented in
Section 6.3.
To determine this, in silico results for 2, 3 and
4-hour osets are presented.
3.6. Retain
The retain step of the cycle stores the evalu-
ated recommendation into the case-base for future
reuse. The complexity of retaining cases largely de-
pends on how the cases are stored. In this work
the case structure remains consistent. However, we
are aware of the importance of case-base mainte-
nance to ensure the search space does not grow to
cause time-complexity issues, and to prevent bad
solutions being retained.
4. Discussion and Analysis of Weka's Fea-
ture Selection Algorithms
To determine the similarity between a problem
and an existing case, it is necessary to consider
the importance of each feature. If the similarity
comparison is conducted with each feature having
equal importance, the result may not be desirable.
Instead, each feature should be weighted in accor-
dance to its ability to correctly predict the outcome.
These weights can then be used in the similarity
comparison to ensure accurate case retrieval.
Determining a weighting for each feature can
be achieved by identifying the relevance between
a feature-value and the outcome. An understand-
ing of the domain may tell us that certain features
are more important than others in determining the
outcome. However, an estimate is not satisfac-
tory, and may vary from subject to subject. In-
stead, weightings can be identied from informa-
tion known to the system, which in this instance
is available through the case-base. In data mining,
the process of feature selection is used to determine
which features are required to reliably predict the
outcome [25]. This allows features of little or no im-
portance to be ignored, which is useful in big data
environments. There are two main approaches to
performing feature selection: subset evaluation and
single-attribute evaluation [18].
Subset evaluators aim to identify the smallest
subset of features which can successfully predict the
outcome [18]. This is usually driven by a random
cycle, which depending on the number of features
present, may or may not include every combination.
In order to prevent excessive computation time, the
process is often limited to a certain number of itera-
tions. Each subset selected is tested to see how reli-
ably the solution can be predicted, and the smallest
possible subset which achieves this is returned.
Single-attribute evaluators do not attempt to
identify the smallest subset of features, and instead
evaluate each feature independently [18]. Each at-
tribute is assigned a numerical result based on its
ability to predict the outcome, which allows for the
features to be ranked.
Both approaches are suitable for feature selec-
tion. However, for the purpose of weighting fea-
tures only the single-attribute evaluators will be
considered. Through performing single-attribute
evaluation on each of the features, the results ob-
tained can be used within the distance function
for feature weighting. The use of feature selection
using single-attribute evaluators is analysed dur-
ing the experimental phase of this research. Sev-
eral well-established attribute evaluators within the
Weka data mining application will be used to obtain
these weightings [3]. Weka provides a number of
single-attribute evaluation algorithms such as Chi-
Squared, Information Gain, Gain Ratio, Symmet-
rical Uncertainty, One Rule, and RELIEF-F [18].
Each of these attribute evaluators are described in
the proceeding subsections. The performance of the
feature selection algorithms for T1DM bolus advice
case retrieval is discussed in Section 6.1.2.
4.1. Chi-Squared
In Weka, Chi-Squared is a single-attribute fea-
ture selection algorithm based on the 2 statistic
[18]. The algorithm seeks to evaluate the 2 value
for a feature in respect to predicting a class by com-
paring the number of observations to the excepted
frequency. The 2 value for any feature is dened
by Eq. 11, where Eij is the expected frequency,
and Oij is the observed frequency for class i with
the feature-value j [26].
2 =
X
i
X
j
(Eij  Oij)2
Eij
(11)
The excepted frequency Eij is dened by Eq. 12,
where nj is the number of instances of the feature
with value j, ni is the number of instances of the
class i, and n is the total number of instances.
Eij =
njni
n
(12)
Any continuous feature-values should be trans-
formed through discretisation into nominal values
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prior to performing the 2 test. Liu and Setiono
presented Chi2, an automated discretisation and
feature selection algorithm using the 2 statistic
[27]. Chi2 is based upon ChiMerge, an algorithm
designed purely to discretise data [28]. Equation
13 denes the ChiMerge algorithm for discretisa-
tion, where C is the total number of classes, Aij is
the number of examples in interval i of class j, Eij
is the expected frequency of Aij = RiCj=N , Ri is
the number of examples in interval i =
PC
j=1Aij ,
Cj is the number of examples in class j =
P2
i=1Aij ,
and N is the total number of examples =
PC
j=1Aij
[28, 26].
2 =
2X
i=1
CX
j=1
(Aij   Eij)2
Eij
(13)
Weka does not adopt the Chi2 or ChiMerge al-
gorithms prior to applying the 2 statistic for fea-
ture selection [18]. Instead, Weka applies a dis-
cretisation method proposed by [29]; a minimum
entropy heuristic which uses the Minimum Descrip-
tion Length Principle (MDLP) to determine useful
cut points for discretising the features [30]. Liu et
al. found using entropy with MDLP to be the best
choice for data discretisation when compared to
other methods including Chi2 and ChiMerge [31].
The same discretisation lter is also applied to the
entropy based feature selection algorithms Infor-
mation Gain, Gain Ratio, and Symmetrical Uncer-
tainty [18]; algorithms which also favour nominal
values [32].
Equation 14 denes the entropy function for dis-
cretisation, which is applied recursively until a stop
criterion is met. Where S1 and S2 are two intervals
of set S bound by cut point T , A is the feature, and
Ent(S) (Eq. 15) is the entropy for a subset of S,
with P (Ci; S) the proportion of examples in S of
class Ci [29, 26].
E(A; T ;S) =
jS1j
jSj Ent(S1) +
jS2j
jSj Ent(S2) (14)
Ent(S) =  
CX
i=1
P (Ci; S) log2(P (Ci; S)) (15)
The criterion for stopping discretisation uses
MDLP, where a partition induced by the cut point
T is only accepted if encoding the partition costs
less than the encoding prior to the split. This stop
criterion is dened by Eq. 16, where N is the num-
ber of instances in the set S, and the distinct classes
present in S, S1, and S2 is c, c1, and c2 respectively
[29, 26].
Ent(S)  E(A; T ;S) > log2(N   1)
N
+
log2(3
c   2)  [cEnt(S)  c1Ent(S)  c2Ent(S)]
N
(16)
4.2. Information Gain
Information Gain is a feature evaluation ap-
proach which uses entropy to evaluate the uncer-
tainty of a feature [33]. This is achieved through
evaluating how the inclusion of additional infor-
mation provided by a feature reduces the entropy.
The entropy of a feature X is determined by Eq.
17, with P (xi) being the frequency of value in X
[34, 32].
H(X) =  
X
i
P (xi) log2(P (xi)) (17)
The entropy of feature X with the additional in-
formation provided by Y is calculated by Eq. 18,
where P (yj) is the frequency of a value in feature
Y , and P (xijyj) is the frequency of a value of X
given the evidence of a value of Y . For classica-
tion, X is the class or outcome and Y is a feature
of the problem.
H(XjY ) =  
X
j
P (yj)
X
i
P (xijyj) log2(P (xijyj))
(18)
Information Gain (Eq. 19) is calculated through
the reduction in entropy of X following the infor-
mation of X provided by Y .
IG(XjY ) = H(X) H(XjY ) (19)
A limitation of the Information Gain algorithm is
the ability to only cater for nominal feature-values.
To resolve this, continuous data is rst partitioned
into nominal values. In Weka, this is achieved using
the MDLP discretisation method.
4.3. Gain Ratio
A limitation of Information Gain is the algo-
rithm's preference to select features containing a
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large quantity of values [33]. This is due to in-
creased partitioning leading to an increased num-
ber of subsets which may only point to a single
class. An example of this would be a unique iden-
tication feature for which each subset would only
contain one case, and subsequently relate to only
one class. This results in the maximal information
gain IG(XjY ) = 1 despite the information being
irrelevant for prediction. To overcome this, an ex-
tension of the Information Gain algorithm was de-
veloped called Gain Ratio. Gain Ratio attempts to
normalise the information gain by factoring in the
useful proportion of information.
Gain Ratio (Eq. 20) is calculated through the
division of the Information Gain (Eq. 19) for X
given the evidence of Y by the entropy of feature
Y (Eq. 17) [26].
GR(X;Y ) =
IG(XjY )
H(Y )
(20)
Gain Ratio has been shown to be robust and
provide consistently better results than Informa-
tion Gain. However, evidence has shown that Gain
Ratio can favour unbalanced splits when one par-
ticular subset is smaller than the others [35].
4.4. Symmetrical Uncertainty
Symmetrical Uncertainty was developed to com-
pensate for Information Gain's preference for fea-
tures with more values, similar to Gain Ratio
[36, 32]. Symmetrical Uncertainty normalises the
value to the range [0; 1], where 1 implies the knowl-
edge provided by a value of Y always predicts the
value of X, and 0 implies the values are completely
independent of each other. Symmetrical Uncer-
tainty is dened by Eq. 21.
SU(X;Y ) = 2

IG(XjY )
H(X) +H(Y )

(21)
4.5. One Rule
One Rule was designed with simplicity in mind
[37]. The algorithm uses the error rate of a feature
as opposed to the entropy approached used by In-
formation Gain. Nevill-Manning et al. describe the
pseudocode for the One Rule algorithm as displayed
in Fig. 3 [38].
One Rule was tested against C4.5 (used to gener-
ate decision trees) on 16 datasets that are regularly
used for evaluation [33]. The results showed that
despite the simple approach taken, One Rule was
for each attribute a, form a rule as follows:
for each value v from the domain of a,
select the set of instances where a
has value v.
let c be the most frequent class in
that set.
add the following clause to the rule
for a:
if a has value v then the class
is c
calculate the classification accuracy of
this rule.
use the rule with the highest classification
accuracy
Figure 3: One Rule pseudocode [38]
only marginally less accurate (by 3.1%) [37]. One
Rule demonstrates that with most real-world data
problems, rules can perform as well as more com-
plex algorithms. In Weka, the One Rule feature se-
lection algorithm performs discretisation using the
same error rate principle [18].
4.6. RELIEF-F
RELIEF-F is an extension of the RELIEF in-
stance based feature ranker [39, 40]. RELIEF was
designed as an ecient method for estimating how
the values of features are able to distinguish be-
tween instances which are near to each other; these
values can either be discrete or continuous. This is
achieved through nding a near-hit and near-miss
instance. A near-hit is an instance which belongs to
the same class and neighbourhood as the instance
being evaluated. A near-miss is an instance in the
same neighbourhood as the instance being evalu-
ated but is not of the same class. A limitation of
the original RELIEF algorithm is its ability to only
deal with a two class problem, which would not
be suitable for this research as there will be more
than two classes of bolus insulin dose available. The
RELIEF-F extension was devised to eliminate this
constraint.
RELIEF-F is the result of incremental de-
velopment of the RELIEF algorithm, starting
with RELIEF-A [39]. RELIEF-A extended RE-
LIEF to include more than one near-hit or near-
miss. RELIEF-B, C and D implemented improve-
ments upon RELIEF-A for dealing with incomplete
datasets. Multi-class problems were introduced
with RELIEF-E by including near-misses from each
class present in the dataset. RELIEF-F improved
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this through averaging the contribution of the near-
misses for each class. This was introduced to allow
the algorithm to estimate the ability a feature has
to separate two classes without considering if they
are closest to each other.
Equation 22 denes RELIEF-F, where m is in
the sample size, diff(A;R;H) is the dierence be-
tween the values of the features in instance R and
H, diff(A;R;M(C)) is the dierence between the
values of the features in instance R and the near
miss instance M(C), and P (C) is the prior proba-
bility of the feature for the class.
W (A) := W (A)  diff(A;R;H)
m
+
X
C 6=class(R)
P (C) diff(A;R;M(C))
m
(22)
4.7. Summary of the Feature Selection Algorithms
This section introduced six feature selection al-
gorithms provided by the Weka data-mining tool.
Three of the algorithms - Information Gain, Gain
Ratio and Symmetrical Uncertainty - use entropy to
determine a features ability to classify. In contrast
Chi-Squared applies the 2 statistic to predicting a
class, One Rule applies error rate, and RELIEF-F
applies a near-hit and near-miss method.
All the algorithms in this section with the excep-
tion of RELIEF-F require features and classes to be
nominal values. As a result, all features with con-
tinuous values should be transformed into nominal
values prior to applying the discussed feature se-
lection algorithms, with the exception of RELIEF-
F. Weka applies the entropy function described by
Fayyad and Irani with MDLP to determine opti-
mal cut points to perform discretisation [29]. This
method is used for all feature selection algorithms
requiring nominal values with the exception of One
Rule, which instead applies the same error rate
principle used in the feature selection process.
It is expected that all the entropy based algo-
rithms - Information Gain, Gain Ratio and Sym-
metrical Uncertainty - will result in similar feature
weightings. However, it is possible that Gain Ratio
and Symmetrical Uncertainty could produce more
accurate weightings than Information Gain, as
these algorithms improve upon Information Gain.
The other algorithms - Chi-Squared, One Rule and
RELIEF-F - all apply dierent methods to feature
selection, and the results are likely to dier for each
algorithm. In terms of execution speed, the One
Rule algorithm is likely to outperform the other al-
gorithms due to its simplistic approach. The opti-
mal algorithm for this system is dicult to predict
and is evaluated during analysis and testing of the
proposed CBR retrieval algorithm in Section 6.1.1.
5. Data Generation and Statistical Measures
This section describes the data and statistical
measures used for evaluating the methodology dis-
cussed in Section 3. We begin by briey describ-
ing the T1DM simulator used for both the genera-
tion of data and in silico evaluation of the proposed
methodology. This is followed by a description of
how we generated sample case-base and problem
set data for the purpose of evaluation. Finally, we
discuss the statistical measures identied for evalu-
ating the eect of bolus recommendations on simu-
lated blood glucose levels.
5.1. UVa/Padova T1DM Simulator
The FDA-approved UVa/Padova T1DM simula-
tor is used in this research to create test data and to
evaluate the proposed CBR model [16]. The simula-
tor allows blood glucose management to be assessed
using closed-loop and open-loop control algorithms.
The closed-loop algorithm acts as an articial pan-
creas, where bolus insulin is automatically calcu-
lated and dosed to the subject as required [41]. In
contrast, the open-loop algorithm is reliant on the
simulated subject administering the bolus insulin
themselves.
Data can be simulated in two ways. One method
is through the user interface, which allows ve
meals at pre-dened times to be input over the
course of multiple days. Alternatively, simulation
can be conducted using a scenario le, which is a
text le that allows various parameters of the simu-
lation to be set with greater exibility. Parameters
include meal times and carbohydrates, simulation
length, bolus times and dose, and closed-loop or
open-loop control. The only inputs required for a
meal to be simulated using closed-loop control is
the quantity of carbohydrates in grams, and the
time of the meal. When using open-loop control,
the bolus insulin dose and time must also be speci-
ed. The results of the simulation can be exported
as minute by minute information on signals such
as bolus doses, basal rate, and blood glucose level.
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This allows for a continuous blood glucose reading
to be obtained for the purpose of analysis and eval-
uation.
The simulator serves two important purposes for
the research and development of our CBR system.
First, the simulator allows for the production of
datasets in order to create sample case-bases and
problem sets through closed-loop simulation. Sec-
ond, the simulator enables bolus suggestions ob-
tained through CBR to analysed and evaluated us-
ing open-loop simulation. The simulator does have
some limitations for this research, including the in-
ability to model physical activity, stress, time pe-
riod based insulin sensitivity factors, and time pe-
riod based carbohydrate-to-insulin ratios.
5.2. Generation of Data Sets for Evaluation
To conduct testing of our method, we require
sample case-bases and sets of problems and the
computation of the feature weights using the fea-
ture selection algorithms. The sample case-bases
and problem sets used for evaluation are as follows:
 5 case-bases, each containing cases over a pe-
riod of 6 months (Section 5.2.1)
 5 problem sets, each containing problems over
the period of 1 month (Section 5.2.2)
5.2.1. Generation of the Sample Case-bases
Test runs of the simulator determined that 6
months of meals can be simulated reliably at any
one time. As a result we chose to limit the size
of the sample case-bases to 6 months of cases. To
generate the case-bases, 6 months of meal informa-
tion are created. These meals are generated ran-
domly with varying time intervals between 120 and
420 minutes, and carbohydrate intakes of 0 to 240
grams [42]. A rule is imposed on these generated
meals to make the earliest meal of the day occur on
or after 7 a.m., this is in order to prevent meals oc-
curring when the subject is likely to be asleep. The
blood glucose level and bolus insulin dose for each
cases are obtained from the simulation of the meal
information. These generated meals provide a wide
variety of realistic meal patterns over a 6 month pe-
riod, with each case-base containing an average of
821 cases.
Following simulation of the meal information, the
simulated blood glucose and bolus insulin signals
require merging with the corresponding meal in-
puts of carbohydrates and time. These blood glu-
cose and bolus insulin values are extracted from the
minute by minute signals exported following simu-
lation using the time the meal occurred during sim-
ulation.
5.2.2. Generating Problem Sets
The same process for generating the sample case-
bases is used to generate sample problem sets. The
problem sets contain 1 month of randomly gener-
ated meals using the same method applied to gen-
erating the sample case-bases discussed in Section
5.2.1. Each problem set is simulated to obtain re-
alistic blood glucose levels for the problem, and the
blood glucose signal exported and merged to com-
plete the problems.
5.2.3. Acquiring Feature Weights Through Feature
Selection Algorithms
Each generated sample case-base is run through
the six feature selection algorithms (Chi-Squared,
Information Gain, Gain Ratio, One Rule, RELIEF-
F, and Symmetrical Uncertainty) in Weka to ac-
quire feature weights for use in the retrieval simi-
larity measure. Prior to importing the case-bases
into Weka, the case-bases are formatted to repre-
sent temporal sequences of up to 5 in length. Each
of the six feature selection algorithms are then per-
formed on the case-bases and the resulting weights
extracted.
5.3. Statistical Measures for Evaluating Bolus In-
sulin Suggestions
To evaluate the CBR system, statistical measures
needed to be identied for analysing and evaluating
the bolus advice obtained through case retrieval.
The data available for testing is limited to infor-
mation about the meals themselves and continu-
ous blood glucose data retrieved from the simula-
tor. For testing purposes, the blood glucose data
provides the best representation of the subject's
well-being, as T1DM management fundamentally
revolves around maintaining safe blood glucose lev-
els. The continuous blood glucose data is generated
through open-loop simulation of the meal informa-
tion input into the CBR system alongside the bo-
lus insulin suggested by the reuse of retrieved cases.
This continuous blood glucose data provides a sim-
ulated blood glucose reading for every minute of the
simulation.
Several statistical measures have been identi-
ed for use on continuous blood glucose data [43]:
blood glucose risk index (BGRI), low blood glucose
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risk index (LBGI), high blood glucose risk index
(HBGI), time within target blood glucose range,
mean, and standard deviation.
5.3.1. Blood Glucose Risk Index
The BGRI can be applied to continuous blood
glucose data to determine overall variance of LBGI
and HBGI [44, 45, 43]. LBGI is used as an
early indicator for detecting potential hypogly-
caemic events, whilst HBGI is used as an indicator
of hyperglycaemic events. These risk indexes are
obtained by splitting the data into low and high
glucose values to assess the variance independently
of each other. Dened boundaries (Table 7) have
been outlined for LBGI and HBGI values to deter-
mine the risk level [44, 45, 46].
Risk level LBGI HBGI
Minimal x  1.1 x < 5.0
Low 1.1 < x  2.5 5.0  x  10.0
Medium 2.5 < x  5.0 10.0 < x  15.0
High x > 5.0 x > 15.0
Table 7: Low and high blood glucose risk index severity levels
[46]
The LBGI and HBGI are calculated by rstly
applying Eq. 23 for blood glucose readings bg in
mmol/L and Eq. 24 for blood glucose readings bg
in mg/dL.
f(bg) = 1:509 (ln(bg)1:084   5:381) (23)
f(bg) = 1:509 (ln(18 bg)1:084   5:381) (24)
The risk function r(bg) for each blood glucose is
calculated by Eq. 25 of the readings.
r(bg) = 10 f(bg) (25)
The results of the risk function are split into two
branches rl for low blood glucose readings (Eq. 26),
and rh for high blood glucose readings (Eq. 27).
rl(bg) =
(
r(bg); if f(bg) < 0
0; otherwise.
(26)
rh(bg) =
(
r(bg); if f(bg) > 0
0; otherwise.
(27)
To calculate LBGI and HBGI, two sequences of
low blood glucose readings LBG and high blood
glucose readings HBG are rstly determined by Eq.
26 and Eq. 27. LBGI is then calculated for the
sequence of low blood glucose readings LBG using
Eq. 28, and HBGI is calculated for the sequence of
high blood glucose readings HBG using Eq. 29.
LBGI(LBG) =
1
jLBGj
jLBGjX
i=1
LBGi (28)
HBGI(HBG) =
1
jHBGj
jHBGjX
i=1
HBGi (29)
Finally, the overall BGRI is calculated through
the sum of LBGI and HBGI as shown in Eq. 30.
BGRI = LBGI +HBGI (30)
Lower values of LBGI and HBGI indicate a lower
risk of hypoglycaemic and hyperglycaemic events
respectively as illustrated by Table. 7. BGRI de-
termines the overall risk of both hypoglycaemic and
hyperglycaemic events, with lower values indicating
a reduced chance of either hypoglycaemic or hyper-
glycaemic events occurring.
5.3.2. Time Within Target Blood Glucose Level
Range
The percentage of time the subject spends within
a pre-dened target range is a good indicator that
the solutions provided by the CBR system are safe
for the subject. The standard target range for
T1DM subjects is between 4 mmol/L and 10.0
mmol/L [47, 48]. The higher the percentage of time
spent within the target range, the better the blood
glucose control. However, the implications of ex-
treme highs and lows are not represented by this
measure.
5.3.3. Mean Blood Glucose Level
The mean () of the blood glucose data pro-
vides a simple approach to determining the sub-
ject's overall well-being, but does not aid in rep-
resenting the variance, extreme lows, and extreme
highs. The optimal target mean blood glucose is
dependent upon the subject's target blood glucose
level, which discounting the 2 hours following a
meal is between 4 mmol/L and 7 mmol/L [48].
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5.3.4. Standard Deviation
Calculating the standard deviation () of the
continuous blood glucose data allows the overall
stability of the subject's blood glucose to be as-
sessed [47]. A high standard deviation indicates
that the subject's blood glucose levels are varying
greatly over time. In contrast, a low standard devi-
ation represents improved stability, and if the sub-
ject is also within the target range, good blood glu-
cose control. Low deviation combined with low or
high blood glucose readings would indicate that the
subject is consistently outside the safe zone.
6. Results
In this section we describe the in silico results of
the approach outlined in Section 3 using the data
sets discussed in Section 5. The results obtained
have been broken down into three sections for the
retrieve, reuse and revise steps of the CBR cycle
in order to highlight how our approach help to pro-
gressively improve the decisions made by the sys-
tem.
6.1. Retrieve
This section describes the in silico results for the
retrieval method described in Section 3.2. First,
a comparison of how dierent temporal sequence
lengths aected the statistical measures. Second,
how the feature selection algorithms eected the de-
cisions made. Finally, a comparison of our method
against two other methods: closed-loop simulation
and a state-of-the-art bolus calculator.
6.1.1. Temporal Sequences
We present the percentage reduction in BGRI of
the dierent temporal sequence lengths (TS2 - TS5)
in comparison to a single temporal case sequence
(TS1 - where no preceding cases are included) for all
feature selection algorithms in Table 8 and Figure
4; where the highest percentage reduction in BGRI
result is best. Overall, retrievals with a temporal
sequence length of 1 (TS1) resulted in the poor-
est predictions, shown by TS2 - TS5 resulting in a
BGRI reduction for all feature selection algorithms
used. This provides some evidence that including
preceding events helps to improve predictions. The
results indicate a decline in BGRI reduction as the
length of the temporal sequences increases. How-
ever, the largest temporal sequence evaluated (TS5)
demonstrated varied retrieval results depending on
the feature selection algorithm used, this is dis-
cussed in more detail in Section 6.1.2.
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Figure 4: Comparison of temporal sequence lengths to no
temporal sequence (TS1), optimising for minimal BGRI, av-
eraged over all feature selection algorithms
6.1.2. Feature Selection Algorithms
The results for the six feature selection algo-
rithms used in isolation are presented in Figure 5.
A notable observation is the improvement in predic-
tion for larger temporal sequences (up to 5) when
using the One Rule algorithm. This algorithm con-
siders features from previous cases to have more
signicant weight than the other algorithms which
explains dierence in these results. For the T1DM
domain One Rule provided favourable results for
greater temporal sequence lengths up to length 5,
however this may not be generalised to other do-
mains.
The similar results obtained using the entropy
based algorithms Information Gain, Gain Ratio
and Symmetrical Uncertainty are expected since
Gain Ratio and Symmetrical Uncertainty are evo-
lutions of the Information Gain algorithm designed
to reduce potential bias for some features [33, 32].
On average, Gain Ratio resulted in the highest
BGRI reduction where t = 2. Additionally, the
results also show Chi-Squared provides similar but
slightly poorer outcomes to the entropy based algo-
rithms.
Overall RELIEF-F resulted in lowest BGRI re-
duction of all the feature selection algorithms used.
One exception is where a single preceding case is in-
volved (TS2), with RELIEF-F outperforming One
Rule, but still falling behind the other four algo-
rithms. In instances where t > 2, RELIEF-F re-
sults in the lowest percentage reduction in BGRI
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Feature Selection Algorithm TS2 TS3 TS4 TS5
Chi-Squared 1.07% 1.02% 0.58% 0.29%
Information Gain 1.21% 0.95% 0.74% 0.23%
Gain Ratio 1.26% 1.11% 0.83% 0.49%
One Rule 0.52% 0.60% 0.81% 1.23%
RELIEF-F 0.72% 0.12% 0.26% 0.26%
Symmetrical Uncertainty 1.20% 1.03% 0.84% 0.39%
Table 8: Percentage reduction in BGRI for dierent temporal sequence lengths to no temporal sequence (TS1)
from TS1.
In summary, we see positive outcomes for all fea-
ture selection algorithms used. Information Gain,
Gain Ratio, Symmetrical Uncertainty and Chi-
Squared demonstrate a similar pattern of BGRI
reduction in correlation to the temporal sequence
length, exhibiting the highest reduction when a sin-
gle preceding case is factored into the retrieval step
(TS2). In contrast, One Rule demonstrates the op-
posite behaviour, improving BGRI reduction as the
temporal sequence length increases up to 5. The
results indicate that Gain Ratio with temporal se-
quence length of 2 results in the highest percent-
age reduction in BGRI (1:26%) in comparison to
TS1; however, other algorithms with the exceptions
of RELIEF-F and Chi-Squared are capable of pro-
ducing similar BGRI reductions depending on the
length of the temporal sequence.
6.1.3. Comparison to Other Methods
In this section the continuous blood glucose re-
sults from CBR retrieval are compared to bolus
suggestions through closed-loop simulation, and the
formula used by the Accu-Chek R Aviva Expert bo-
lus calculator. Both the closed-loop simulation and
bolus calculator were applied to the same ve prob-
lem sets used to evaluate CBR retrieval. The bolus
calculator results were computed and then simu-
lated using open-loop simulation to obtain continu-
ous blood glucose levels. The results are compared
to the optimal retrieval conguration, and are vi-
sualised in Fig. 6.
The mean statistical results across all ve prob-
lems sets using closed-loop simulation can be seen
in Table 9. As the sample case-bases were created
using the simulator it is expected that the CBR re-
sults would be similar if the retrieval algorithm can
correctly identify similar cases. The BGRI, LBGI
and HBGI continuous blood glucose results for the
CBR suggestions and closed-loop simulation (Fig.
6) yield, as expected, similar results. This provides
evidence that the retrieval algorithm is identifying
appropriate cases within the case-base.
Measure Value
BGRI 4.34
LBGI 2.11
HBGI 2.20
<TR % 0.12
>TR % 0.00
2 0.79
 0.89
 6.37
Table 9: Closed-loop simulation statistics
Table 10 displays mean continuous blood glu-
cose results for the bolus calculator advice. The
results show that the bolus calculator outperforms
both the simulator and the CBR retrievals. This
provides evidence that the formulas used by the
state-of-the-art bolus calculators can produce reli-
able and accurate results. These results provide re-
assurance, as one potential method of building the
initial case-base for the subject is through utilising
an existing formula.
Measure Value
BGRI 4.21
LBGI 1.92
HBGI 2.29
<TR % 0.00
>TR % 0.00
2 0.76
 0.87
 6.49
Table 10: Bolus calculator statistics
The state-of-the-art bolus calculator results ques-
tion whether performing CBR retrieval on a case-
base produced by the calculation formula will re-
sult in similar performance. To test this, the op-
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(c) Gain Ratio
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(f) Symmetrical Uncertainty
Figure 5: Comparison of various temporal sequence lengths to no temporal sequence (TS1) for the dierent feature selection
algorithms
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timal retrieval conguration is tested against case-
bases produced by the bolus calculator as opposed
to closed-loop simulation.
The case-bases were identical to those used previ-
ously, but the bolus solutions are replaced by those
obtained from the bolus calculator. The results
shown in Table 11 demonstrate similar CBR re-
trieval results to those produced by the bolus cal-
culator, with a marginal improvement in some sta-
tistical measures. This is visualised in Fig. 7 where
the original results are shown in addition to CBR
retrieval on the bolus calculator case-base.
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Figure 6: Comparison of CBR, simulated and bolus calcula-
tor results
Measure Value
BGRI 4.14
LBGI 1.87
HBGI 2.26
<TR % 0.00
>TR % 0.00
2 0.74
 0.86
 6.48
Table 11: CBR retrieval result for case-bases produced by a
bolus calculator
The comparison of the CBR retrieval results to
the other methods show evidence that the retrieval
method discussed is capable of selecting reliable bo-
lus advice when presented with a new problem. The
results also show that the quality of the CBR sug-
gestions is related to the quality of the cases re-
tained in the case-base.
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Figure 7: Comparison of CBR to other methods including
CBR with bolus calculator case-base
Measure Without IOB With IOB
BGRI 4.22 0.31 3.94 0.27
LBGI 2.09 0.23 1.96 0.23
HBGI 2.13 0.16 1.98 0.26
< TR % 0.03 0.19 0.01 0.12
> TR % 0.00 0.00 0.00 0.00
 0.87 0.05 0.81 0.04
 mmol/L 6.34 0.13 6.30 0.21
Table 12: Comparison without and with insulin-on-board
adaptation
6.2. Reuse
Insulin-on-board adaptation was tested against
a combination of ve case-base sets using the op-
timal retrieval conguration. The purpose of the
IOB adaptation is to resolve the dierences in ac-
tive insulin between the new problem and retrieved
case(s). Table 12 and Figure 8 illustrate the im-
provement IOB adaptation provides across all sta-
tistical measures.
The results show some improvement in overall
blood glucose control with IOB adaptation, with a
6.6% reduction in BGRI, in addition to a reduc-
tion in deviation. The decrease in both LBGI and
HBGI suggests that the adaptation rule is able to
correctly decrease or increase the bolus insulin sug-
gestion to account for dierences between the IOB
of the new problem and retrieved case(s). This pro-
vides evidence that including this adaptation rule
in the reuse step of the CBR system does help to
improve the bolus advice. As the results only show
a slight improvement from the pre-adaptation so-
lution, it provides an indication that temporal se-
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quences help to reduce the eect of insulin stack-
ing. Since the goal is to seek the optimal solution,
any adjustment which can improve the suggestion
is benecial to the system.
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Figure 8: BGRI, LBGI and HBGI before and after IOB
adaptation
6.3. Revise
Successful revision is crucial for CBR to learn
from mistakes. To test the eectiveness of the revi-
sion rule described in Section 3.5, the bolus insulin
solutions following IOB adaptation were subject to
ve cycles of postprandial evaluation. Three sets of
results are recorded for postprandial blood glucose
readings taken at 2, 3 and 4 hours after the bolus
dose. The test cycles aim to determine the eect
on the simulated continuous blood glucose level us-
ing same the statistical measures to evaluate the
retrieval process. The target blood glucose for the
subject is set as 6.66 mmol/L, and TDD used to
estimate ISF is calculated using Eq. 9 over 4 pre-
ceding days, where each day has at least three meals
recorded. A daily basal dose of 20 insulin units is
added to each of the 4 days, as dened for the sub-
ject by the simulator. For instances where the pro-
ceeding bolus dose occurs before the postprandial
evaluation oset time, the oset is adjusted to 15
minutes prior to the time of the proceeding bolus
dose.
Results for ve cycles of postprandial blood glu-
cose evaluation and revision using readings 2 hours
post meal bolus are displayed in Table 13. The re-
sults display gradual improvements in all statistical
measures for each evaluation cycle with the excep-
tion of HBGI, which shows a slight rise following
the fourth cycle, but is still well below the minimal
risk boundary of less than 5.0. From observing the
results of increased oset times (discussed below),
the most likely cause for this slight rise in HBGI
is due to the short oset time. The mean blood
glucose level statistic demonstrates how the revised
bolus insulin doses on average result in a continu-
ous blood glucose level closer to the target blood
glucose level of 6.66 mmol/L.
Table 14 displays postprandial evaluation results
for blood glucose readings taken 3 hours post meal
bolus. Increasing the postprandial evaluation o-
set time to 3 hours shows improvements to all sta-
tistical measures where an improvement can oc-
cur in comparison to the 2-hour oset. Most no-
tably, LBGI is reduced to the minimum risk cate-
gory ( 1:1) after three cycles of evaluation. The
increased oset time also removed the rise in HBGI
observed in the 2-hour oset.
The nal postprandial evaluation uses a 4-hour
oset and is presented in Table 15. The results
show a slight degradation in blood glucose control
in comparison to the 3-hour oset, this is likely due
to duration of active insulin in simulation.
Visualisation of the postprandial evaluation revi-
sion results for BGRI, LBGI, HBGI and standard
deviation are displayed in Figures 9. The trend
graphs illustrate the improvements in blood glu-
cose control with increased learning cycles. Most
notably, the 3-hour oset produces improved blood
glucose control over both the 2-hour and 4-hour o-
sets. Cycle 0 in the trend graphs represent the
original continuous blood glucose results prior to
postprandial evaluation.
The postprandial evaluation results indicate that
the postprandial blood glucose oset time is key to
the quality of the bolus revision, with an oset time
of 3 hours demonstrating the best revision results
over 2-hour and 4-hour osets. With a 3-hour o-
set, a decrease in BGRI of 27% is observed after
three cycles of revision, pushing up to 28.7% af-
ter ve cycles. This demonstrates the importance
of revision to CBRs ability to learn, as shortcom-
ings of the solution can only be observed through
simulation or real-world use. The results demon-
strate that an automated approach to bolus dose
revision is possible within our CBR system, allow-
ing the user to quickly evaluate the solution and
obtain improved bolus insulin suggestions in future
reuse.
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Measure Original Cycle 1 Cycle 2 Cycle 3 Cycle 4 Cycle 5
BGRI 3.94 0.27 3.50 0.30 3.29 0.32 3.21 0.32 3.18 0.34 3.17 0.34
LBGI 1.96 0.23 1.59 0.24 1.40 0.25 1.31 0.24 1.27 0.23 1.25 0.23
HBGI 1.98 0.26 1.91 0.31 1.89 0.20 1.89 0.29 1.91 0.19 1.92 0.20
< TR % 0.01 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
> TR % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
 0.81 0.04 0.74 0.04 0.71 0.04 0.69 0.04 0.69 0.04 0.69 0.04
 mmol/L 6.30 0.21 6.40 0.17 6.46 0.15 6.50 0.15 6.53 0.14 6.54 0.14
Table 13: Bolus reuse following 2-hour oset postprandial evaluation
Measure Original Cycle 1 Cycle 2 Cycle 3 Cycle 4 Cycle 5
BGRI 3.94 0.27 3.32 0.31 3.02 0.41 2.87 0.43 2.82 0.44 2.81 0.41
LBGI 1.96 0.23 1.41 0.17 1.14 0.14 1.00 0.14 0.95 0.16 0.94 0.15
HBGI 1.98 0.26 1.91 0.25 1.88 0.28 1.87 0.29 1.87 0.28 1.87 0.28
< TR % 0.01 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
> TR % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
 0.81 0.04 0.72 0.03 0.67 0.04 0.65 0.04 0.64 0.04 0.64 0.04
 mmol/L 6.30 0.21 6.44 0.15 6.52 0.13 6.56 0.12 6.58 0.12 6.58 0.12
Table 14: Bolus reuse following 3-hour oset postprandial evaluation
Measure Original Cycle 1 Cycle 2 Cycle 3 Cycle 4 Cycle 5
BGRI 3.94 0.27 3.33 0.26 3.04 0.37 2.92 0.41 2.89 0.40 2.89 0.37
LBGI 1.96 0.23 1.41 0.19 1.14 0.13 1.02 0.14 0.99 0.14 0.99 0.14
HBGI 1.98 0.26 1.93 0.25 1.90 0.27 1.90 0.27 1.90 0.27 1.90 0.37
< TR % 0.01 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
> TR % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
 0.81 0.04 0.72 0.03 0.68 0.04 0.66 0.04 0.65 0.04 0.65 0.04
 mmol/L 6.30 0.21 6.43 0.16 6.50 0.14 6.53 0.13 6.54 0.13 6.54 0.13
Table 15: Bolus reuse following 4-hour oset postprandial evaluation
7. Threats to Validity
We have only applied this approach for temporal
sequences in case-based reasoning to insulin advice
for diabetic subjects. This, along with other threats
raises some potential issues as far as the validity of
the approach concerned.
For construct validity we must ask if the BGRI
measure is the right one to use. However, this is the
de-facto standard measure for blood glucose risk
levels, so we believe it is the best metric in this
situation.
For internal validity we ask whether we achieved
a good outcome as a result of chance. This is un-
likely since the work took many years with the
results being averages of several sample problem
and case-base sets. The results were also compared
against a control without temporal sequences.
As far as external validity is concerned, which
asks whether we can generalise our results, the ap-
proach outlined in Section 3 requires evaluation
with dierent case-bases in other domains. With all
feature weighting algorithms temporal sequences up
to a length of 5 resulted in improved insulin predic-
tions when compared no use of temporal sequences
(t = 1). In other domains factors from previous
cases may also need to be tested before temporal
sequences can be validated as a prediction aid.
Another threat to external validity is the need
for continuous features. Whilst distance functions
which cater for nominal values do exist, the ap-
proach cannot be applied in domains where re-
trieval is based upon heuristics or abstraction rules.
The approach is also aimed towards case-bases
where the features remain the same throughout the
case-base; there is a potential diculty to overcome
in domains where the features may vary from case
to case such as in cross-domain systems. The choice
of temporal sequence length is likely to be highly
domain dependant and may require trial and error
following an initial hypothesis to determine the op-
timal length.
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Figure 9: Results of reusing revised bolus suggestions over 0 to 5 cycles of revision
Finally, the approach is heavily reliant on feature
weighting to ensure that all the features in the con-
catenated temporal case reect their true weight in
identifying the most similar case(s). As a result, the
selection of a suitable feature weighting algorithm
or expert advice is crucial to ensure that features
are represented correctly.
8. Related Work
Case-based reasoning has been adopted by sev-
eral research projects in the domain of T1DM. The
majority of this research has focused on aiding clini-
cians with therapy adjustments as opposed to help-
ing the patient directly as our work does. Such
projects include the T-IDDM project [49], and more
recently the IDSDM project [50]. A notable ex-
ception is the Advanced Bolus Calculator for Dia-
betes (ABC4D) [51, 52], which through clinical tri-
als demonstrated the benets of CBR for bolus ad-
vice. ABC4D's CBR approach involves the tuning
of ISF and CIR for a small set of meal scenarios.
The ISF and CIR are values from the most sim-
ilar case are then plugged into a standard bolus
calculator to suggest a bolus dose. Our approach
instead retains all successful cases and derives the
bolus suggestion from the most similar cases, allow-
ing the introduction of the temporal retrieval algo-
rithm presented in this work. This may introduce
time complexity issues as the case-base grows; how-
ever, structures such as a k-dimensional tree can be
introduced and case-base maintenance rules estab-
lished to minimise this problem [53].
Several dierent approaches for temporal case-
based reasoning have been explored, with the ma-
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jority focusing on the prediction of future events.
Jaczynski proposed a CBR framework with the abil-
ity to retrieve cases composed of time series fea-
tures [10]. Each time series represents the variants
of a variable over time, catering for both numerical
samples and changes of state. This work presents a
general framework for time-extended situations and
focuses on domains with continuous data streams
from multiple sources (e.g. sensors) as opposed to
the recorded instances of a traditional CBR system.
Jre, et al. investigate the use of Allen's theory
of temporal intervals to avoid faults through pre-
diction in the CBR system CREEK [11, 54]. In
contrast to creating a sequence of events from con-
crete cases, CREEK uses interval relationships to
form a temporal relationship.
Another approach to temporal reasoning is tem-
poral projection, introduced by Branting and Hast-
ings [55]. Temporal projection shifts retrieved cases
forwards or backwards through a method such as
simulation to match the new problem. The case
with the greatest similarity following a shift is then
selected. This approach represents cases very dif-
ferently and uses time shifts instead of temporal
sequences.
The aforementioned methods do not cater for
the formation of temporal sequences from isolated
cases. To overcome this Sanchez-Marre, et al. pro-
pose that a sequence of continuous cases can be
merged into a singular case [12]. This method al-
lows the temporal sequences to be compared using
standard distance metrics without the need for ad-
ditional rules. In the work conducted by Sanchez-
Marre, et al., plausible episodes are generated from
a new problem, which are then compared to similar
retrieved episodes in order to solve the new prob-
lem [12]. This work uses a similar approach with
the formation of episodes and serves as the founda-
tions for our work.
9. Conclusion
Successful management of T1DM is a dicult
task for subjects due to the complexity of the con-
dition. As a result, subjects often seek methods to
aid their ability to successfully manage the condi-
tion through good blood glucose control. Successful
management of blood glucose levels reduces the risk
of long-term complications.
State-of-the-art bolus calculators for T1DM pro-
vide a means for bolus advice, but are reliant on
continuous medical advice from a doctor for opti-
mal conguration. This research demonstrates pos-
itive in silico results for the use of temporal CBR
as an alternative for bolus decision support.
The temporal CBR method proposed in this re-
search enhances the retrieval step through the intro-
duction of temporal sequences and dynamic feature
weighting, resulting in better case retrieval in com-
parison to the traditional approach of single case
comparison. Temporal sequences allow factors from
previous events to be considered when identifying
the most similar case, which is an important consid-
eration in temporal domains. Additionally, the re-
search utilises domain specic rules to enable auto-
matic adaptation and revision, allowing the system
to both improve suggestions and optimise future
advice. Results of these domain specic adaptation
and revision rules show signicant improvement in
simulated blood glucose control and highlight the
potential of CBR for bolus advice.
The method can be adopted by insulin pumps,
blood glucose monitors, personal computers, and
as a web service accessible from any device with in-
ternet access. The potential versatility allows for
a widely accessible intelligent solution to bolus ad-
vice.
The CBR system could be extended further to in-
clude features (due to the limitations of the T1DM
simulator). Some features omitted in this research
which should explored include exercise, stress and
alcohol. An expanded system with clinical trials
would provide a real-world insight into the viabil-
ity of temporal CBR for T1DM self-management.
There is potential to increase the performance of
the proposed retrieval process through the inclu-
sion of dimensional matching to reduce the number
of cases requiring an aggregate match. Improve-
ments to eciency will increase the range of de-
vices for which CBR in this domain would be vi-
able. As the majority of eciency concerns reside
in the retrieval process, a cloud service would be
an approach to consider. Such an approach would
have to be implemented carefully to prevent issues
associated with network access, which is an area of
concern for quality of experience.
A CBR service in the cloud also opens up the
possibility of case sharing between subjects. This
would reduce the need for a case-base to be cre-
ated using a traditional bolus calculator or similar
method, potentially allowing CBR to be used with-
out the need to create a case-base. For case sharing
to be reliable, a suitable method for identifying the
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similar subjects would be required. Additionally,
steps would need to be taken to ensure the security
and condentiality of any stored user information
and address the issue of patient trust.
Some elements of this research also have the po-
tential for use in other domains. Most notably the
use of temporal sequences to improve case retrieval
in temporal and sequential domains. Research into
the use of temporal sequences in other domains will
help provide evidence to validate the method. Ex-
amples of such use may be other medical condi-
tions which require self-management, project cost-
estimation for software-engineering, and the predic-
tion of future events in a number of domains based
on sequential events. There are certainly questions
to be asked about how to determine optimal tem-
poral sequence length, possibly through a hypothe-
sis by domain experts which can then be validated
through simulated or real-world testing. Addition-
ally, the use of temporal sequences is highly depen-
dent on feature weighting, so future research could
explore the use of dierent algorithms, or explore
how the algorithms used in this research perform in
other domains.
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